Results 91 to 100 of about 5,988 (201)

Clinical Outcomes of Colorectal Endoscopic Full‐Thickness Resection Using the Full‐Thickness Resection Device: A Multicenter Study

open access: yesDEN Open, Volume 7, Issue 1, April 2027.
ABSTRACT Background Endoscopic full‐thickness resection (EFTR) using the full‐thickness resection device (FTRD) is an emerging technique for the management of complex colorectal lesions and early colorectal cancers. Although EFTR offers a minimally invasive alternative to surgery, data on efficacy, safety, and predictors of adverse events (AEs) remain ...
Vicki McGarrigle   +20 more
wiley   +1 more source

Treatment of Venous Thromboembolism in Special Populations with Direct Oral Anticoagulants [PDF]

open access: yesZhongguo quanke yixue
Direct oral anticoagulants (DOACs) have been approved for the treatment and secondary prevention of venous thromboembolism (VTE), and have achieved stable application among clinicians in recent years, with an expanding scope of use.
XIAO Yao, WAN Jun
doaj   +1 more source

Evaluation of Large Language Models in the Clinical Management of Patients With Upper Gastrointestinal Bleeding: Insights From Real‐World Patient Data

open access: yesDEN Open, Volume 7, Issue 1, April 2027.
Large language models are evaluated for pre‐endoscopy risk stratification and prediction of endoscopic findings in patients with upper gastrointestinal bleeding. Their performance is compared with validated clinical risk scores, conventional machine learning models, and hybrid approaches.
Mohsen Rajabnia   +7 more
wiley   +1 more source

Secondary prophylaxis of venous thromboembolism with direct oral anticoagulants (DOACs) in patients with major congenital thrombophilia

open access: yes, 2020
Secondary prophylaxis of venous thromboembolism with direct oral anticoagulants (DOACs) in patients with major congenital ...
Chistolini, Antonio   +4 more
core   +1 more source

Main outcomes with DOACs from studies reporting a similar or higher incidence of major complications than MACACOD.

open access: yes, 2023
Main outcomes with DOACs from studies reporting a similar or higher incidence of major complications than MACACOD.
René Acosta-Isaac (14241647)   +6 more
core   +1 more source

PERBANDINGAN WARFARIN DAN DIRECT ORAL ANTICOAGULANTS (DOACS) PADA OPTIMISASI MANAJEMEN RISIKO TROMBOEMBOLI PADA FIBRILASI ATRIUM [PDF]

open access: yes
Fibrilasi Atrium (FA) merupakan gangguan irama jantung yang meningkatkan risiko tromboemboli, termasuk stroke. Penelitian ini membandingkan efektivitas, keamanan, dan farmakoekonomi antara Warfarin dan Direct Oral Anticoagulants (DOACs), khususnya ...
Nur, St. Harlyanti   +2 more
core   +1 more source

Post‐Endoscopic Retrograde Cholangiopancreatography Bleeding After Endoscopic Stone Removal in Dialysis Patients: A Multicenter Retrospective Study

open access: yesDEN Open, Volume 7, Issue 1, April 2027.
ABSTRACT Objectives Post‐endoscopic retrograde cholangiopancreatography (post‐ERCP) bleeding occurs more frequently in dialysis patients than in non‐dialysis patients. This study aimed to identify risk factors for post‐ERCP bleeding following stone removal in patients undergoing dialysis.
Masaki Nishimura   +16 more
wiley   +1 more source

Baseline characteristics of patients treated with DOACs (cases) or warfarin (controls).

open access: yes, 2019
Baseline characteristics of patients treated with DOACs (cases) or warfarin (controls).
Gualtiero Palareti (743533)   +11 more
core   +1 more source

Risk of Delayed Post‐polypectomy Bleeding in Patients With Antithrombotic Therapy

open access: yesDEN Open, Volume 7, Issue 1, April 2027.
Antithrombotic therapy is associated with an increased risk of delayed post‐polypectomy bleeding after endoscopic resection of colorectal polyps ≤15 mm. Despite this increased risk, overall bleeding rates remain low in both per‐patient and per‐lesion analyses. ABSTRACT Objectives Recent changes in the perioperative management of antithrombotic therapy (
Rumiko Tsuboi   +18 more
wiley   +1 more source

Plasma levels for different doses of DOACs at different time points.

open access: yes, 2019
Plasma levels for different doses of DOACs at different time points.
Yvonne M. C. Henskens (3753562)   +7 more
core   +1 more source

Home - About - Disclaimer - Privacy